Susquehanna International Group, LLP Acurx Pharmaceuticals, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 48,374 shares of ACXP stock, worth $35,796. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,374Holding current value
$35,796% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ACXP
# of Institutions
31Shares Held
1.36MCall Options Held
9.3KPut Options Held
9.7K-
Vanguard Group Inc Valley Forge, PA529KShares$391,7180.0% of portfolio
-
Prospect Financial Services LLC Melville, NY329KShares$243,5160.15% of portfolio
-
Geode Capital Management, LLC Boston, MA147KShares$108,4100.0% of portfolio
-
Morgan Stanley New York, NY46.2KShares$34,1880.0% of portfolio
-
State Street Corp Boston, MA43.5KShares$32,1640.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $8.55M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...